Sysmex Corp 2023 IR

The report highlights Sysmex's performance and strategic initiatives for fiscal 2022, showcasing record-high sales of 410.5 billion yen. The company launched its new Long-Term Corporate Strategy 2033 (VA33), focusing on the 'healthcare journey' to expand its business domains from diagnostics to personalized prevention and treatment. Key achievements during the year included receiving manufacturing and marketing approval in Japan for an Alzheimer's disease blood-testing reagent and expanding the insurance coverage of its robotic-assisted surgery system. Additionally, Sysmex strengthened its global presence by entering a new global OEM agreement with Siemens Healthineers in the hemostasis field and acquiring Astrego Diagnostics to accelerate rapid antimicrobial susceptibility testing.

Company: Sysmex Corp

Sector: Health Care

Country: Japan

Year: 2023

Type: IR

Pages: 56

Back to company

Sysmex Corp

Sysmex Corp 2023 Integrated Report

Integrated Report

The report highlights Sysmex's performance and strategic initiatives for fiscal 2022, showcasing record-high sales of 410.5 billion yen. The company launched its new Long-Term Corporate Strategy 2033 (VA33), focusing on the 'healthcare journey' to expand its business domains from diagnostics to personalized prevention and treatment. Key achievements during the year included receiving manufacturing and marketing approval in Japan for an Alzheimer's disease blood-testing reagent and expanding the insurance coverage of its robotic-assisted surgery system. Additionally, Sysmex strengthened its global presence by entering a new global OEM agreement with Siemens Healthineers in the hemostasis field and acquiring Astrego Diagnostics to accelerate rapid antimicrobial susceptibility testing.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2023

Reporting Period

Apr 1, 2022 - Mar 31, 2023

Fiscal Year

2022

Type

Integrated Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Women on Board

Women in Management

Net Zero Target

Employees